Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Beyda

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Diagnostic Microbiology and Infectious Disease|October 19, 2013
Comparison of the T2Dx instrument with T2Candida assay and automated blood culture in the detection of Candida species using seeded blood samplesNicholas D Beyda, M Jahangir Alam, Kevin W Garey
Microbiology Spectrum|May 10, 2022
A Vancomycin HPLC Assay for Use in Gut Microbiome ResearchChenlin Hu, Nicholas D Beyda, Kevin W Garey
The Annals of Pharmacotherapy|July 20, 2012
Echinocandin resistance in Candida species: mechanisms of reduced susceptibility and therapeutic approachesNicholas D Beyda, Russell E Lewis, Kevin W Garey
Microbiology Spectrum|February 2, 2022
Clumping Morphology Influences Virulence Uncoupled from Echinocandin Resistance in Candida glabrataChenlin Hu, Gary Fong, Sebastian Wurster, et al.
Pharmacotherapy|April 17, 2023
Micafungin pharmacodynamics predict clinical outcomes in hospitalized patients with candidemia caused by certain Candida speciesAhmed Zaki, Anne J Gonzales-Luna, Nicholas D Beyda, et al.
Antimicrobial Agents and Chemotherapy|June 24, 2015
Innate inflammatory response and immunopharmacologic activity of micafungin, caspofungin, and voriconazole against wild-type and FKS mutant Candida glabrata isolatesNicholas D Beyda, Guangling Liao, Bradley T Endres, et al.
Mycopathologia|September 1, 2014
Host factors and clinical outcomes of Candida colonization in critically ill patientsDavid M Jacobs, Nicholas D Beyda, Orarik Asuphon, et al.
Diagnostic Microbiology and Infectious Disease|August 21, 2019
Comparative in vitro pharmacodynamic analysis of isavuconazole, voriconazole, and posaconazole against clinical isolates of aspergillosis, mucormycosis, fusariosis, and phaeohyphomycosisRussell E Lewis, Sebastian Wurster, Nicholas D Beyda, et al.
Antimicrobial Agents and Chemotherapy|November 8, 2017
Overtreatment of Asymptomatic Candiduria among Hospitalized Patients: a Multi-institutional StudyDavid M Jacobs, Thomas J Dilworth, Nicholas D Beyda, et al.
Pharmacotherapy|September 27, 2017
Early Administration of Adjuvant β-Lactam Therapy in Combination with Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Retrospective, Multicenter AnalysisAnthony M Casapao, David M Jacobs, Dana R Bowers, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Diagnostic Microbiology and Infectious Disease|October 19, 2013
Comparison of the T2Dx instrument with T2Candida assay and automated blood culture in the detection of Candida species using seeded blood samplesNicholas D Beyda, M Jahangir Alam, Kevin W Garey
Microbiology Spectrum|May 10, 2022
A Vancomycin HPLC Assay for Use in Gut Microbiome ResearchChenlin Hu, Nicholas D Beyda, Kevin W Garey
The Annals of Pharmacotherapy|July 20, 2012
Echinocandin resistance in Candida species: mechanisms of reduced susceptibility and therapeutic approachesNicholas D Beyda, Russell E Lewis, Kevin W Garey
Microbiology Spectrum|February 2, 2022
Clumping Morphology Influences Virulence Uncoupled from Echinocandin Resistance in Candida glabrataChenlin Hu, Gary Fong, Sebastian Wurster, et al.
Pharmacotherapy|April 17, 2023
Micafungin pharmacodynamics predict clinical outcomes in hospitalized patients with candidemia caused by certain Candida speciesAhmed Zaki, Anne J Gonzales-Luna, Nicholas D Beyda, et al.
Antimicrobial Agents and Chemotherapy|June 24, 2015
Innate inflammatory response and immunopharmacologic activity of micafungin, caspofungin, and voriconazole against wild-type and FKS mutant Candida glabrata isolatesNicholas D Beyda, Guangling Liao, Bradley T Endres, et al.
Mycopathologia|September 1, 2014
Host factors and clinical outcomes of Candida colonization in critically ill patientsDavid M Jacobs, Nicholas D Beyda, Orarik Asuphon, et al.
Diagnostic Microbiology and Infectious Disease|August 21, 2019
Comparative in vitro pharmacodynamic analysis of isavuconazole, voriconazole, and posaconazole against clinical isolates of aspergillosis, mucormycosis, fusariosis, and phaeohyphomycosisRussell E Lewis, Sebastian Wurster, Nicholas D Beyda, et al.
Antimicrobial Agents and Chemotherapy|November 8, 2017
Overtreatment of Asymptomatic Candiduria among Hospitalized Patients: a Multi-institutional StudyDavid M Jacobs, Thomas J Dilworth, Nicholas D Beyda, et al.
Pharmacotherapy|September 27, 2017
Early Administration of Adjuvant β-Lactam Therapy in Combination with Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Retrospective, Multicenter AnalysisAnthony M Casapao, David M Jacobs, Dana R Bowers, et al.
Pageof 3